January 26, 2018 / 11:29 PM / 9 months ago

BRIEF-Repros Announces Negative Opinion From The EMA For Enclomiphene

Jan 26 (Reuters) - Repros Therapeutics Inc:

* REPROS ANNOUNCES NEGATIVE OPINION FROM THE EMA FOR ENCLOMIPHENE

* CHMP HAS FORMALLY ISSUED A NEGATIVE OPINION FOR CENTRALIZED MAA FOR ENCLOMIPHENE FOR TREATMENT OF SECONDARY HYPOGONADISM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below